What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

Marta Vives-Pi; Irma Pujol-Autonell

doi:10.2217/nnm.15.140

What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?

Marta Vives-Pi, Irma Pujol-Autonell

Department of Cellular Biology, Physiology and Immunology

Research output: Contribution to journal › Review article › Research › peer-review

Original language	English
Pages (from-to)	2955-2958
Journal	Nanomedicine
Volume	10
Issue number	19
DOIs	https://doi.org/10.2217/nnm.15.140
Publication status	Published - 1 Oct 2015

Keywords

autoimmunity
immunotherapy
liposomes
nanomedicine
Type 1 diabetes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/nnm.15.140

Cite this

@article{1bc1087f9d0941f4a2d41fe5a3b2d228,

title = "What potential is there for liposomal-based nanotherapy for the treatment of Type 1 diabetes?",

keywords = "autoimmunity, immunotherapy, liposomes, nanomedicine, Type 1 diabetes",

author = "Marta Vives-Pi and Irma Pujol-Autonell",

year = "2015",

month = oct,

day = "1",

doi = "10.2217/nnm.15.140",

language = "English",

volume = "10",

pages = "2955--2958",

journal = "Nanomedicine",

issn = "1743-5889",